How Is My Site?

View Results

Loading ... Loading ...

    Forum Posts by
    Adriane Fugh-Berman

    • EpiPen Furor: Patient Groups Take Money, Stay Mum

      Posted on August 29, 2016

      The furor around the price of an EpiPen has exposed the contradictions of patient advocacy groups with funding from the pharmaceutical industry. EpiPens contain epinephrine, an oldie-but-goodie, inexpensive generic drug that effectively treats potentially life-threatening allergic reactions. Pharmaceutical companies put this common, inexpensive drug into expensive, auto-injecting devices, which are useful, portable devices for those… Read more

    • The Drug that Cried “Feminism”

      Posted on March 17, 2015

      Branded as “The Little Pink Pill” and “Female Viagra,” flibanserin, Sprout Pharmaceuticals’ only drug, was recently resubmitted to the Food and Drug Administration for approval for hypoactive sexual desire disorder (HSDD), a questionable condition promoted by pharmaceutical companies to sell questionable drugs. Flibanserin, a failed-antidepressant-turned-libido-boosting-drug, has already been rejected twice by the FDA due to… Read more

    • LEGGO the Logo? Why Pharma Logos Belong on CME

      Posted on May 19, 2014

      Several weeks ago, the Accreditation Council for Continuing Medical Education (ACCME) announced a new rule banning corporate logos from accredited educational materials for physicians. The ACCME sets standards for the continuing medical education (CME) that most practicing physicians must obtain in order to renew their licenses. Pharmaceutical companies often fund CME, and previously chose whether… Read more

    • Rounding Up Scientific Journals

      Posted on January 10, 2014

      Scientific journal publishing reached a low point in November, when the journal Food and Chemical Toxicology retracted a study by Gilles-Eric Séralini and colleagues at Caen University in France. The study, published in November 2012, assessed the effect of feeding rats corn genetically modified to withstand treatment with Monsanto’s herbicide Roundup for two years (that is a lifetime… Read more

    • Low-T, High Profit?

      Posted on August 20, 2012

      An unusually lengthy and undoubtedly expensive 90-second commercial for Androgel aired during men’s swimming and volleyball events in NBC’s coverage of the Olympics. The ad touts Androgel 1.62%, a more concentrated formulation of Abbott Laboratories’ testosterone treatment, and starts by addressing “the millions of men who have used Androgel 1%.” Millions of men may have used Androgel,… Read more

    Get updates from The Hastings Center
    Interests